US Stock MarketDetailed Quotes

PMN ProMIS Neurosciences

Watchlist
  • 1.950
  • 0.000-0.02%
Close Apr 25 16:00 ET
36.97MMarket Cap-1822P/E (TTM)

About ProMIS Neurosciences Company

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Company Profile

SymbolPMN
Company NameProMIS Neurosciences
Listing DateJul 8, 2022
Founded2004
CEOMr. Neil K. Warma
MarketNASDAQ
Employees6
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1920 Yonge Street,Suite 200
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM4S 3E2
Phone1-416-847-6898
Websitehttp://www.promisneurosciences.com

Company Executives

  • Name
  • Position
  • Salary
  • Neil K. Warma
  • Director, President and Interim Chief Executive Officer
  • 40.00K
  • Johanne Kaplan
  • Chief Development Officer
  • --
  • Daniel E. Geffken, M.B.A.
  • Chief Financial Officer
  • --
  • Dr. Neil Cashman
  • Chief Scientific Officer and Director
  • 577.72K
  • Gavin T. Malenfant
  • Chief Operating Officer
  • 413.49K
  • Larry Douglas Altstiel
  • Chief Medical Officer
  • --
  • Max A. Milbury
  • Senior Director, Finance and Principal Accounting Officer
  • --
  • Eugene Williams
  • Chairman of the Board
  • 683.14K
  • Patrick D. Kirwin
  • Independent Director
  • 40.00K
  • Dr. Madge K. Shafmaster, PhD
  • Lead Independent Director
  • 40.00K
  • Joshua Mandel-Brehm
  • Independent Director
  • 40.00K
  • William Wyman
  • Independent Director
  • 40.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg